LENZ Therapeutics, Inc. Common Stock (NASDAQ: LENZ) last traded at $4.68, up 0.43% on the session. The quote above updates while this page is open; the figures below are drawn from LENZ Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
LENZ Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker LENZ. Its market capitalisation is $147.05 million.
Valuation measures for LENZ Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $147.05M |
|---|---|
| Enterprise value | $140.17M |
| Price / sales | 6.85 |
| Price / book | 0.67 |
| Beta | 1.37 |
Trailing-twelve-month figures tagged in LENZ Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $21.48M |
|---|---|
| Net income (TTM) | -$126.00M |
| EPS (TTM) | -$4.13 |
| Operating margin | -631.70% |
| Return on equity | -57.47% |
| Cash | $24.21M |
Range and volume for LENZ over the past 52 weeks.
| 52-week high | $50.40 |
|---|---|
| 52-week low | $4.54 |
| Volume | 474.3K |
| Average volume | 865.7K |
| Previous close | $4.66 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.